Results

Total Results: 923 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
    January 01, 2015 - patients who cannot initiate or who cannot tolerate metformin remains unclear. … outcomes will be especially useful to clinicians, patients, investigators, guideline developers, and … Patients and patient advocates also will find the information valuable when making decisions about treatment … • We will exclude studies of patients with type 1 diabetes, impaired glucose tolerance, metabolic … using a co-morbidity scale or index; by including other medical conditions or medications used by the patient
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-rapid-research.pdf
    May 01, 2025 - of their care, including communication with doctors and nurses, responsiveness of staff, and other indicators … Toolkit To Improve Safety for Mechanically Ventilated Patients. … Toolkit for Engaging Patients To Improve Diagnostic Safety. … https://www.ahrq.gov/diagnostic- safety/tools/engaging-patients-improve.html. … /diagnostic-safety/tools/engaging-patients-improve.html https://www.ahrq.gov/diagnostic-safety/tools/
  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
    September 01, 2011 - are made in the report, its conclusions should have clinical applicability because they laid out the safety … Objective outcomes addressed include esophagitis healing, ambulatory pH, other indicators of reflux, … placebo in improving asthma symptoms, nocturnal asthma, or use of asthma medications, or in objective indicators … Administrative databases can provide additional data for addressing long-term safety issues. … Objective outcomes addressed include esophagitis healing, ambulatory pH, other indicators of reflux,
  4. S131 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - Presented at the Agency for Healthcare Research and Quality meeting on “Comparative Effectiveness and Safety … competitors within a class are often marketed for better efficacy, slightly expanded indications, or better safety … Baseline patient characteristics are presented in Table 1. … the effectiveness and safety of a particular drug that I am about to start and continue to use, compared … , we identified a set of restrictions that analysts should consider in epidemiologic studies of the safety
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
    August 23, 2013 - Similarly in studies that did not have access to patient medical charts or patient interviews, how was … Similarly, a recent FDA Drug Safety Communication that addressed bleeding events in patients taking … In addition, apixaban in particular showed safety and efficacy when compared to aspirin in patients … 75) and younger patients for both efficacy and safety. … Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
    October 30, 2019 - Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and … Recommendation: Based on the evidence, all DOACS have shown safety and efficacy in patients who are … The safety population is used, which is the same population used in other DOAC trials to assess safety … Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease … Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
    November 27, 2012 - For this reason, it is also important to capture long-term safety to obtain a global aspect of how … these therapies impact patient care, both benefits and harms. … For KQ 1, what does this patient population look like? … Efficacy and safety of infliximab vs. … One patient was reported to have hypertension in patients who switched from methotrexate to infliximab
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
    October 18, 2010 - Terbutaline sulfate is commonly used in selected patients as a maintenance therapy to inhibit uterine … Further, as the level of care offered to patients and the level of activity of patients on continuous … subcutaneous terbutaline might differ from that of patients on comparative treatments, we will explore … Therefore, in addition to conducting heterogeneity analyses by other indicators of true preterm labour … to ensure only one event is recorded per patient, in the case the same patient experiences multiple
  9. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
    October 01, 2014 - DBS to the subcallosal cingulate white matter supported the long-term safety and antidepressant efficacy … The safety of ECT in patients with an implanted DBS system has not been established. … ketamine would have a minimal impact on health outcomes in the absence of data on long-term effects, safety … Efficacy and safety of mifepristone for the treatment of psychotic depression. … Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects
  10. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - data and postmarket safety evaluation—set forth by the U.S. … Kushner and colleagues announced results from a phase III clinical trial (SEQUEL) evaluating the safety … However, a potential increase in per-patient cost might serve as a barrier to acceptance by some patients … While preliminary results are promising, further studies evaluating efficacy and safety are needed, … Safety and efficacy study of EndoBarrier in subjects with type II diabetes and obesity.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
    August 01, 2007 - Microsoft Word - ehcrr#2toCSI.doc Effective Health Care Number 2 Research Reports Comparative SafetyPatients. … Older Patients. … The older patient: the ongoing challenge of efficacy and tolerability. … The efficacy, safety, and tolerability of antipsychotics in the elderly.
  12. effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
    August 13, 2012 - end-users and facilitates appropriate translation of the results into health care practice and use by patient … If the FDA approves, human testing for safety and efficacy can begin. … These endpoints may be categorized as clinical endpoints, patient-reported outcomes and quality of … On the other hand, a patient who has a health condition where there are few treatments may be willing … Likewise, some patient groups were reported to be concerned by the decision since it presumably would
  13. S116 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
    October 01, 2007 - pharmacoepidemiology, prescribing (Med Care 2007;45: S116–S122) Observational studies are necessary to evaluate the safety … For the IV to be defined for each patient, we excluded each physician’s first patient from the cohort … Characteristics of Cohort Patient Characteristics N % Female patient 12,545 81.5 Age �80 10,750 70.0 … Indeed, in a comparative safety study of APMs in a population of seniors in British Columbia, Canada, … 0.78 �0.58, 1.02� 0.07 Patient of PCPs 0.98 �0.70, 1.39� 0.93 Long-acting benzodiazepines All patients
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
    November 15, 2012 - every other week, for the life of the patient. … What are the potential safety issues and harms with ERT? 2. … What published and unpublished studies have reported on the use and safety of this intervention? … Adverse events/harms/safety issues reported 4. … patient and one parent of a child patient will be consulted.
  15. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
    January 01, 2016 - for calibrating the CGM (as applicable) and checking sensor performance as needed plus associated reagents … But the experts called for longer safety and efficacy studies to determine whether this system would … Genentech has a patient assistance program to help defray costs for qualified patients.135 Several … Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to … Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus
  16. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
    December 04, 2015 - Within each KQ, we will assess outcomes for subgroups of patients or studies based on patient and clinical … (patientsafety, effectiveness, and policy challenges. … Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and … Drug Safety. 2011 Aug 1;34(8):651-68. PMID: 21751826. 17.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
    May 01, 2013 - Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression Comparative … Effectiveness Research Review Disposition of Comments Report Research Review Title: Efficacy and Safety … Efficacy and Safety of Screening for Postpartum Depression. Comparative Effectiveness Review 106. … What are community patients? … It can be considered unethical to screen women without a safety net and protocol in place.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
    January 01, 2024 - prescribed cannabis (2) Whole-plant cannabis, “certified 12.5% THC” (CBD NR) route determined by patient … final mean dose 16.6/15.4 mg THC/CBD/day vs. 17.2 mg THC/day None specified; based on individual patient … a Patients could choose any medicinal product they preferred in these studies. … Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in … Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-protocol.pdf
    January 01, 2023 - stakeholders, clinical specialists, experts in patient safety issues, and a patient/consumer perspective … groups 6 Study Parameter Inclusion criteria Exclusion criteria • Patients receiving care … /products/prioritization-patient-safety-practices https://effectivehealthcare.ahrq.gov/products/prioritization-patient-safety-practices … The TEP included 15 experts in patient safety with representa... … To accomplish that task, we will review AHRQ’s Patient Safety Networ...
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - • The following outcomes were added: patient or parent/caregiver preferences, work-related functional … outcomes, patient insight into illness. … followup), patient baseline characteristics (diagnosis and age at diagnosis, age, sex, race, weight … in each group, and the number of patients affected. … Adults Pediatric use: safety & effectiveness not established in patients <18 yr 1. agranulocytosis

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: